Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Diclofenac Dosing for Arthritic Pain Management

Initial Treatment Approach

  • Paracetamol should be the first-line treatment for painful joints attributed to degenerative arthritis, in doses of up to 4 g daily, as recommended by the guideline society, with a strength of evidence not specified 1
  • If paracetamol fails to provide adequate relief, NSAIDs like ibuprofen (starting at 1200 mg daily) should be considered before moving to diclofenac, according to the BMJ, with a strength of evidence not specified 2
  • If relief remains inadequate with ibuprofen, diclofenac can be considered as an alternative NSAID option, as suggested by the BMJ, with a strength of evidence not specified 2

Safety Considerations

  • Gastrointestinal complications are the most frequent adverse effects of diclofenac, and consider gastroprotective agents (H2 blockers, misoprostol, proton pump inhibitors) in high-risk patients, as recommended by Praxis Medical Insights, with a strength of evidence not specified 3
  • Risk of serious gastrointestinal complications increases with higher doses, according to the BMJ, with a strength of evidence not specified 2
  • NSAIDs, including diclofenac, may delay natural healing processes as inflammation is a necessary component of tissue recovery, as noted by Praxis Medical Insights, with a strength of evidence not specified 3

Common Pitfalls to Avoid

  • Do not start with diclofenac before trying paracetamol and then ibuprofen, as this contradicts evidence-based guidelines, as recommended by the BMJ and Praxis Medical Insights, with a strength of evidence not specified 1, 2
  • Avoid combining diclofenac with other NSAIDs as this increases risk of adverse effects without providing additional benefit, as recommended by Praxis Medical Insights, with a strength of evidence not specified 1
  • Be aware that high-dose ibuprofen (2.4 g daily) may be no safer than intermediate-risk NSAIDs like diclofenac, according to the BMJ, with a strength of evidence not specified 2